Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Modeling NK-Cell Lymphoma in Mice Reveals Cell-of-Origin, Microenvironment, and Therapeutic Targets

Blood (2024) 144 (Supplement 1): 1608.

https://doi.org/10.1182/blood-2024-207082

Published: 2024

Journal Articles

TP53 and CDKN2A alterations Define a Poor Prognostic Subgroup in Patients with Nodal T-Follicular Helper Cell Lymphoma

Blood (2023) 142 (Supplement 1): 1630.

https://doi.org/10.1182/blood-2023-173638

Published: 2023

Journal Articles

Frequent Alterations of Driver Genes in Chromosome X and Their Clinical Relevance in Extranodal NK/T-Cell Lymphoma

Yuta Ito, Amira Marouf, Yasunori Kogure, Junji Koya, Mariko Tabata, Yuki Saito, Sumito Shingaki, Mitsuhiro Yuasa, Kentaro Yamaguchi, Julie Bruneau, Manon Vavasseur, Michaël Dussiot, Isabelle Andre, Akshay Joshi, Chantal Lagresle-Peyrou, Aude Magerus, Sammara Chaubard, David Lavergne, Emmanuel Bachy, Erika Brunet, Virginie Fataccioli, Chantal Brouzes, Camille Laurent, Laurence De Leval, Alexandra Traverse-Glehen, Céline Bossard, Marie Parrens, Véronique Meignin, Laure Philippe, Julien Rossignol, Felipe Suarez, Jean-Marie Michot, Olivier Tournilhac, Christine Bole-Feysot, Patrick Nitschke, Bruno Tesson, Cécile Laurent, Thierry Jo Molina, Vahid Asnafi, Sachiko Tsukita, Koji Izutsu, Hiroaki Miyoshi, Seiji Sakata, Akito Dobashi, Kengo Takeuchi, Koichi Ohshima, Philippe Gaulard, Arnaud Jaccard, Seishi Ogawa, Olivier Hermine, Keisuke Kataoka, Lucile Couronne

Blood (2022) 140 (Supplement 1): 1737–1739.

https://doi.org/10.1182/blood-2022-159869

Published: 2022

Journal Articles

A Single-Cell Atlas of Nonhematopoietic Cells in Human Lymph Node and Lymphoma Reveals Landscape of Stromal Remodeling

Blood (2021) 138 (Supplement 1): 447.

https://doi.org/10.1182/blood-2021-145718

Published: 2021

Journal Articles

Frequent genetic alterations in immune checkpoint–related genes in intravascular large B-cell lymphoma

Blood (2021) 137 (11): 1491–1502.

https://doi.org/10.1182/blood.2020007245

Published: 2021

Includes: Supplemental data

Journal Articles

VAV1 mutations contribute to development of T-cell neoplasms in mice

Kota Fukumoto, Mamiko Sakata-Yanagimoto, Manabu Fujisawa, Tatsuhiro Sakamoto, Hiroaki Miyoshi, Yasuhito Suehara, Tran B. Nguyen, Sakurako Suma, Shintaro Yanagimoto, Yuichi Shiraishi, Kenichi Chiba, Alyssa Bouska, Keisuke Kataoka, Seishi Ogawa, Javeed Iqbal, Koichi Ohshima, Shigeru Chiba

Blood (2020) 136 (26): 3018–3032.

https://doi.org/10.1182/blood.2020006513

Published: 2020

Includes: Supplemental data

Journal Articles

VAV1 Mutations Contributes to the Development of T-Cell Malignancies in Mice

Kota Fukumoto, MD, Mamiko Sakata-Yanagimoto, MD PhD, Manabu Fujisawa, MD, Tatsuhiro Sakamoto, MD PhD, Tran B. Nguyen, Sakurako Suma, MD, Hiroaki Miyoshi, MD PhD, Koichi Ohshima, MD PhD, Keisuke Kataoka, MD PhD, Seishi Ogawa, MD PhD, Shigeru Chiba, MD PhD

Blood (2019) 134 (Supplement_1): 300.

https://doi.org/10.1182/blood-2019-124591

Published: 2019

Journal Articles

Paics Inhibition Is a Potential Therapeutic Strategy for MYC-Positive DLBCL

Kohta Miyawaki, MD PhD, Takuji Yamauchi, MD PhD, Takeshi Sugio, MD PhD, Kensuke Sasaki, MD, Hiroaki Miyoshi, MD PhD, Simon Osborne, PhD, Deborah Taylor, PhD, Koichi Ohshima, MD PhD, Koji Kato, MD PhD, Takahiro Maeda, MD PhD, Koichi Akashi, MD PhD

Blood (2019) 134 (Supplement_1): 396.

https://doi.org/10.1182/blood-2019-129613

Published: 2019

Journal Articles

Splenic B-Cell Lymphoma/Leukemia, Unclassifiable in Japan

Takaharu Suzuki, MD, Hiroaki Miyoshi, MD PhD, Keisuke Kawamoto, MD PhD, Joji Shimono, MD PhD, Jun Takizawa, MD PhD, Masao Seto, MD PhD, Koichi Ohshima, MD PhD

Blood (2018) 132 (Supplement 1): 5301.

https://doi.org/10.1182/blood-2018-99-113239

Published: 2018

Journal Articles

In Situ Hybridization of HBZ and Tax in FFPE Samples from ATLL Patients and Its Association with Clinicopathological Characteristics

Kyohei Yamada, MD, Hiroaki Miyoshi, MD PhD, Mai Takeuchi, MD PhD, Naoko Asano, MD PhD, Joji Shimono, MD PhD, Fumiko Arakawa, PhD, Kazutaka Nakashima, Kensaku Sato, PhD, Masao Seto, MD PhD, Koichi Ohshima, MDPhD

Blood (2018) 132 (Supplement 1): 1643.

https://doi.org/10.1182/blood-2018-99-112082

Published: 2018

Journal Articles

Lymphoma Microenvironment Signature Predicts Clinical Outcomes in Diffuse Large B-Cell Lymphoma Patients

Kohta Miyawaki, MD, Takeshi Sugio, MD, Koji Kato, MD PhD, Kensuke Sasaki, MD, Hiroaki Miyoshi, MDPhD, Jon C. Aster, MD PhD, Frank C Kuo, MBBS, PhD, Koichi Ohshima, MDPhD, Takahiro Maeda, MDPhD, Koichi Akashi, MD PhD

Blood (2017) 130 (Supplement 1): 1474.

https://doi.org/10.1182/blood.V130.Suppl_1.1474.1474

Published: 2017

Journal Articles

Novel Subtypes Based on Microenvironment Immune Signature Provides Prognostic Stratification and Therapeutic Strategy in Peripheral T-Cell Lymphoma

Takeshi Sugio, MD, Kohta Miyawaki, MD, Kensuke Sasaki, MD, Koji Kato, MD PhD, Hiroaki Miyoshi, MDPhD, Koichi Ohshima, MDPhD, Takahiro Maeda, Koichi Akashi, MD PhD

Blood (2017) 130 (Supplement 1): 1453.

https://doi.org/10.1182/blood.V130.Suppl_1.1453.1453

Published: 2017

Journal Articles

Clinicopathological Study of Methotrexate-Associated Lymphoproliferative Disorders in Rheumatoid Arthritis Patients: Histological Classification and Predictive Factors for Disease Progression

Daisuke Kurita, MD, Hiroaki Miyoshi, MDPhD, Ayako Ichikawa, MDPhD, Yuya Sasaki, MD, Keisuke Kawamoto, MDPhD, Joji Shimono, MD, Masao Matsuoka, MDPhD, Masahiro Kizaki, MDPhD, Masao Seto, MD PhD, Jun-ichi Tamaru, MDPhD, Michihide Tokuhira, MD, Koichi Ohshima, MDPhD

Blood (2017) 130 (Supplement 1): 4168.

https://doi.org/10.1182/blood.V130.Suppl_1.4168.4168

Published: 2017

Journal Articles

Clinical and Prognostic Significance of Epstein-Barr Virus in Diffuse Large B-Cell Lymphoma

Shinichiro Matsuda, Ritsuro Suzuki, MD PhD, Masaya Inoue, Ritsuko Seki, PhD, Koji Nagafuji, Hiroaki Miyoshi, Koichi Ohshima, MD PhD, Junji Suzumiya

Blood (2016) 128 (22): 108.

https://doi.org/10.1182/blood.V128.22.108.108

Published: 2016

Journal Articles

Structural Variations Involving Programmed Death Ligands in B-Cell and T-Cell Lymphomas

Keisuke Kataoka, MD PhD, Hiroaki Miyoshi, MD PhD, Yasunori Kogure, MD, Yasuharu Sato, MD PhD, Kenji Nishida, MD, Yuichi Shiraishi, PhD, Hiroko Tanaka, BA, Kenichi Chiba, BA, Yosaku Watatani, MD, Yusuke Shiozawa, MD, Kenichi Yoshida, MD PhD, Masashi Sanada, MD PhD, Motohiro Kato, MD PhD, Satoru Miyano, PhD, Koji Izutsu, MD PhD, Kengo Takeuchi, MD PhD, Tadashi Yoshino, MD PhD, Koichi Ohshima, MD PhD, Seishi Ogawa, MD PhD

Blood (2016) 128 (22): 4105.

https://doi.org/10.1182/blood.V128.22.4105.4105

Published: 2016

Journal Articles

Delineation of Novel Subtypes Based on Microenvironment Immune Signature Provides Prognostic Stratification Strategy in Peripheral T-Cell Lymphoma

Takeshi Sugio, MD, Kohta Miyawaki, MD, Koji Kato, MD PhD, Hiroaki Miyoshi, MD PhD, Koichi Ohshima, MD PhD, Koichi Akashi, MD PhD

Blood (2016) 128 (22): 4108.

https://doi.org/10.1182/blood.V128.22.4108.4108

Published: 2016

Journal Articles

Molecular Heterogeneity in Peripheral T-Cell Lymphoma Not Otherwise Specified Revealed By Comprehensive Mutational Profiling

Yosaku Watatani, MD, Yasuharu Sato, MD PhD, Kenji Nishida, MD, Hiroaki Miyoshi, MD PhD, Yuichi Shiraishi, PhD, Kenichi Chiba, BA, Tanaka Hiroko, Hiroo Ueno, MD, Nobuyuki Kakiuchi, MD, Yusuke Shiozawa, MD, Tetsuichi Yoshizato, MD PhD, Kenichi Yoshida, MD PhD, Masashi Sanada, MD PhD, Satoru Miyano, PhD, Koichi Ohshima, MD PhD, Tadashi Yoshino, MD PhD, Seishi Ogawa, MD PhD, Keisuke Kataoka, MD PhD

Blood (2016) 128 (22): 2927.

https://doi.org/10.1182/blood.V128.22.2927.2927

Published: 2016

Journal Articles

Expression Pattern of Immunosurveillance-Related Antigen Is a Critical Prognostic Factor of Adult T-Cell Leukemia/Lymphoma

Naoko Asano, MD PhD, Hiroaki Miyoshi, MD PhD, Takeharu Kato, MD, Joji Shimono, MD, Noriaki Yoshida, MD PhD, Daisuke Kurita, MD, Yuya Sasaki, MD, Keisuke Kawamoto, MD, Koichi Ohshima, MD PhD, Masao Seto, MD PhD

Blood (2016) 128 (22): 4135.

https://doi.org/10.1182/blood.V128.22.4135.4135

Published: 2016

Journal Articles

PD-L1 expression on neoplastic or stromal cells is respectively a poor or good prognostic factor for adult T-cell leukemia/lymphoma

Hiroaki Miyoshi, Junichi Kiyasu, Takeharu Kato, Noriaki Yoshida, Joji Shimono, Shintaro Yokoyama, Hiroaki Taniguchi, Yuya Sasaki, Daisuke Kurita, Keisuke Kawamoto, Koji Kato, Yoshitaka Imaizumi, Masao Seto, Koichi Ohshima

Blood (2016) 128 (10): 1374–1381.

https://doi.org/10.1182/blood-2016-02-698936

Published: 2016

Journal Articles

Clinical Significance of MYC, BCL2 and BCL6 Rearrangement and Protein Expression in GCB and Non-GCB Type Diffuse Large B-Cell Lymphoma

Keisuke Kawamoto, MD, Jun Takizawa, MD, Hiroaki Miyoshi, MD, Noriaki Yoshida, MD, Yasuhiko Shibasaki, MD, Masayoshi Masuko, MD, Hirohito Sone, MD, Naoya Nakamura, MD PhD, Koichi Ohshima, MD PhD

Blood (2015) 126 (23): 1445.

https://doi.org/10.1182/blood.V126.23.1445.1445

Published: 2015

NARROW

Modeling NK-Cell Lymphoma in Mice Reveals Cell-of-Origin, Microenvironment, and Therapeutic Targets

TP53 and CDKN2A alterations Define a Poor Prognostic Subgroup in Patients with Nodal T-Follicular Helper Cell Lymphoma

Frequent Alterations of Driver Genes in Chromosome X and Their Clinical Relevance in Extranodal NK/T-Cell Lymphoma

A Single-Cell Atlas of Nonhematopoietic Cells in Human Lymph Node and Lymphoma Reveals Landscape of Stromal Remodeling

Frequent genetic alterations in immune checkpoint–related genes in intravascular large B-cell lymphoma

VAV1 mutations contribute to development of T-cell neoplasms in mice

VAV1 Mutations Contributes to the Development of T-Cell Malignancies in Mice

Paics Inhibition Is a Potential Therapeutic Strategy for MYC-Positive DLBCL

Splenic B-Cell Lymphoma/Leukemia, Unclassifiable in Japan

In Situ Hybridization of HBZ and Tax in FFPE Samples from ATLL Patients and Its Association with Clinicopathological Characteristics

Lymphoma Microenvironment Signature Predicts Clinical Outcomes in Diffuse Large B-Cell Lymphoma Patients

Novel Subtypes Based on Microenvironment Immune Signature Provides Prognostic Stratification and Therapeutic Strategy in Peripheral T-Cell Lymphoma

Clinicopathological Study of Methotrexate-Associated Lymphoproliferative Disorders in Rheumatoid Arthritis Patients: Histological Classification and Predictive Factors for Disease Progression

Clinical and Prognostic Significance of Epstein-Barr Virus in Diffuse Large B-Cell Lymphoma

Structural Variations Involving Programmed Death Ligands in B-Cell and T-Cell Lymphomas

Delineation of Novel Subtypes Based on Microenvironment Immune Signature Provides Prognostic Stratification Strategy in Peripheral T-Cell Lymphoma

Molecular Heterogeneity in Peripheral T-Cell Lymphoma Not Otherwise Specified Revealed By Comprehensive Mutational Profiling

Expression Pattern of Immunosurveillance-Related Antigen Is a Critical Prognostic Factor of Adult T-Cell Leukemia/Lymphoma

PD-L1 expression on neoplastic or stromal cells is respectively a poor or good prognostic factor for adult T-cell leukemia/lymphoma

Clinical Significance of MYC, BCL2 and BCL6 Rearrangement and Protein Expression in GCB and Non-GCB Type Diffuse Large B-Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only